Last reviewed · How we verify
NCT05478421
Radiographic Bone Volume Alteration After Jaw Cyst Enucleation With Different Bone Grafts
NA trial testing Collagen sponge in Jaw Cysts in 80 participants. Status unknown.
30 January 2024
Quick facts
| Lead sponsor | The Dental Hospital of Zhejiang University School of Medicine |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 1 June 2022 |
| Primary completion | 30 January 2024 |
| Estimated completion | 30 September 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Collagen sponge
- GBR
- CS/GBR
Conditions studied
- Jaw Cysts — all drugs for Jaw Cysts →
Sponsor
The Dental Hospital of Zhejiang University School of Medicine
Who can join
Adults 18 to 80, any sex, with Jaw Cysts. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
For decades, implantology has attracted extensive interest for restoration in patients with the defect of dentition. It has emerged as a very established prosthetic with a 5-year survival rate of 96% . However, defect of dentition resulted from jaw cyst remains an ongoing challenge for subsequent implantation treatment. Since it presents as a larger bone lesion than normal teeth extraction sockets and bone quality and quantity in teeth missing area can significantly impact dental implant failure rates . Jaw cysts are one of the most common diseases occurring in the oral and maxillofacial area, and often cause destructive bone lesions followed by specific clinical features, such as located pain, swelling and loosen teeth. Over the years, enucleation of jaw bone cysts has been the standard method of management of jaw cysts because its conservational protocol to remove the lesion thoroughly and reserve important structures and functions. Unfortunately, management of the residual bony cavity remains as a huge dilemma whether to filing the defect with additional material. Clot formation in the first instance is the conventional option for residual cavity recovery. Iodoform sponges are traditionally used in cysts as stuffing material for inflammation preventative purpose, however, it cannot help with the following bone formation. Without any bone filling material, researches revealed that spontaneous bone healing index can be from 25.85% to 76% and from 43.46% to 81.03% after 6 and 12 months post-operative respectively. These ranged results indicated that spontaneous bone healing is not efficient enough especially for patients with the extraction of relevant teeth who may process a subsequent surgery for implantation. As an alternative to this, bone graft material in the surgery has gained increasing attention. Autogenous bone, artificial bone substitutes and mix of them are widely applied to achieve higher bone regeneration. Thereby an alternative surgical procedure should be considered for patients at risk of missing teeth because of jaw cysts. Whether bone graft material could make a remarkable improvement of bone regeneration after cyst enucleation and would this actually benefit the follow-up implantation? Answers are urged to be delivered. Based on the published data, few studies have yielded in the bone healing comparison of spontaneous bone healing and xenograft in jaw cysts. Besides, with the development of medical radiograph, three-dimensional images have played a more important role in the clinic. Whereas, to our knowledge, most researches had adopted two-dimensional radiograph for measurement, such as panoramic radiographs rather than three dimensions. Therefore, we conducted a prospective study to evaluate the shrinkage rate in cyst patients with different extra xenograft (Bio-Oss and collagen sponge). Cone beam computed tomography (CBCT) and three-dimensional model reconstruction were recommended for radiographic and digital analyzation. In summary, this study was aimed to evaluate bone volume augmentation after jaw cyst enucleation with different bone substitutes filling by CBCT and to analyze other influence factors for bone formation as well.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05478421
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Collagen sponge
Trials testing the same drug.
- NCT07086482 — Effect of Cyanoacrylate Tissue Adhesive Versus Collagen Sponge on Palatal Donor Site Healing · EARLY_PHASE1 · recruiting
- NCT06783660 — PeptiCol EZgraft in the Extraction Socket Preservation Process After Tooth Extraction · NA · recruiting
Other recruiting trials for Jaw Cysts
Currently open trials in the same condition.
- NCT07424716 — Bone Regeneration Using PRF After Cyst Enucleation · NA · recruiting
- NCT06567535 — Treatment of Mandibular Bone Cyst by Navigation and Endoscopy · NA · recruiting
Other The Dental Hospital of Zhejiang University School of Medicine trials
Trials by the same sponsor.
- NCT07334067 — Site Preservation Was Performed Through an Open Healing Oral Restorative Membrane · NA · not yet recruiting
- NCT07388901 — In Vivo Study on the Material Properties of iRoot SP and nRoot SP Root Canal Sealers · NA · recruiting
- NCT06449391 — The Application of Root Analogy Implant in Immediate Implantation · NA · recruiting
- NCT06031896 — The Severity of Periodontitis at the Buccal and Palatal Site · unknown
- NCT05275803 — Lactobacillus Reuteri for Non-surgical Periodontal Treatment of Chronic Periodontitis With Type 2 Diabetes Patients · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05478421 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by The Dental Hospital of Zhejiang University School of Medicine
- Last refreshed: 28 July 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05478421.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing